Parties d'ouvrages collectifs (4)
2.
Gelfand, E. E., Simon, D., Simon, H.-U., Thomas, P. A., Busse, W. W., Nair, P., Gauvreau, G. G., Denburg, J. J., Bivins-Smith, E. E., Jacoby, D., Davis, B. B., Rothenberg, M., Khoury, P., Klion, A., Lotfi, R., Spada, N., Lotze, M. T., Schleimer, R. R., Kato, A., Kern, R., Lavigne, M. M., Eppihimer, M. M., Roufosse, F., Le Moine, A., Massart, A., Benghiat, F., Lemaitre, P., Krahn, M., Bartoli, M., & Levy, N. (2013). Eosinophils in Human Disease. In Eosinophils in Health and Disease (pp. 431-536). Elsevier Inc. doi:10.1016/B978-0-12-394385-9.00013-44.
Roufosse, F., Massart, A., Benghiat, F., Lemaitre, P., & Le Moine, A. (2012). Eosinophils and Allograft Rejection. In J. L. Lee & H. F. Rosenberg (Eds.), Eosinophils in Health and Disease. Academic Press, Elsevier. Articles dans des revues avec comité de lecture (116)
1.
Fagnoul, S., Ghisdal, L., Marangoni, M., Detry, C., Dacremont-Rodrigues, P., Bisteau, X., Imbault, V., Catalano, C., Smits, G., Le Moine, A., & Migeotte, I. (2026). A Partial UMOD Deletion Results in Altered UMOD Synthesis and ADTKD. Kidney Medicine, 101265. doi:10.1016/j.xkme.2026.1012652.
Gemander, N., Kemlin, D., Depickère, S., Kelkar, N. N., Sharma, S., Pannus, P., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Baudoux, T., Vandevenne, M., Goossens, M. M., Matagne, A., Desombere, I., Ariën, K. K., Ackerman, M. M., Le Moine, A., & Marchant, A. (2025). COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients. Vaccine, 44, 126544. doi:10.1016/j.vaccine.2024.1265443.
Diamante Chiodini, B., Guillaume-Gentil, P., Vanhomwegen, C., Hennaut, E., Lolin, K., Tram, N., Le Moine, A., & Ismaili, K. (2024). BK Polyomavirus in Pediatric Renal Transplantation—What We Know and What We Do Not. Biomedicines, 12(5), 1093. doi:10.3390/biomedicines120510934.
Van Meerhaeghe, T., Murakami, N., Le Moine, A., Brouard, S., Sprangers, B., & Degauque, N. (2024). Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients. Clinical Kidney Journal, 17(4), sfae061. doi:10.1093/ckj/sfae0615.
Gemander, N., Kemlin, D., Depickère, S., Kelkar, N. N., Pannus, P., Sharma, S., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Vandevenne, M., Goossens, M. M., Matagne, A., Desombere, I., Ariën, K. K., Ackerman, M. M., Le Moine, A., & Marchant, A. (2024). Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients. Kidney International Reports, 9(3), 635-648. doi:10.1016/j.ekir.2023.12.0086.
Ayyach, A. A., Le Moine, A., Kaci, L., Royer-Chardon, C., Ghisdal, L., Marangoni, M., Smits, G., & Nortier, J. (2023). Salt-losing tubulopathy worsening the prognosis of renal sarcoidosis. JOHNS. Journal of otolaryngology, head and neck surgery, 36(3), 627-630. doi:10.1007/s40620-022-01538-z8.
Van Meerhaeghe, T., Baurain, J.-F., Bechter, O., Orte Cano, C., Del Marmol, V., Devresse, A., Doubel, P., Hanssens, M., Hellemans, R., Lienard, D., Rutten, A., Sprangers, B., Le Moine, A., & Aspeslagh, S. (2022). Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients. Nephrology frontier, 2, 1041819. doi:10.3389/fneph.2022.1041819